Cannabis tea revisited: A systematic evaluation of the cannabinoid composition of cannabis tea

Journal of Ethnopharmacology

Volumn 113, Issue 1, 2007, Pages 85-90

  Hazekamp, Arno ^a   Bastola, Krishna ^a   Rashidi, Hassan ^a   Bender, Johan ^b   Verpoorte, Rob ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b Farmalyse BV   (Netherlands)

Author keywords

Cannabinoids; Cannabis; Decoction; Medicinal use; Quantitative analysis

Indexed keywords

CANNABINOID; CANNABIS; DRONABINOL; TETRAHYDROCANNABINOLIC ACID;

ARTICLE; DRUG DETERMINATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; QUANTITATIVE ANALYSIS;

BETA-CYCLODEXTRINS; CANNABINOIDS; CANNABIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; DRUG STORAGE; NETHERLANDS; SOLUBILITY; TEA; TETRAHYDROCANNABINOL;

CANNABIS;

EID: 34447562769     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.05.019     Document Type: Article

References (23)

1. Boekhout van Solinge T. Ganja in Jamaica. Amsterdams Drug Tijdschrift 2 (1996) 11-14
2. De Jong F.A., Engels F.E., Sparreboom A., Loos W.J., De Bruijn P., Friberg L.E., Mathot R.A., Verweij J., and Mathijssen R.H. Influence of medicinal cannabis (MC) on the pharmacokinetics (PK) of docetaxel (DOC) and irinotecan (CPT-11). AACR Meeting Abstracts (2005) 938c-939c
3. Fetterman P.S., Keith E.S., Waller C.W., Guerrero O., Doorenbos N.J., and Quimby M.W. Mississippi-grown Cannabis sativa L. Preliminary observation on chemical definition of phenotype and variations in tetrahydrocannabinol content versus age, sex, and plant part. Journal of Pharmaceutical Sciences 60 (1971) 1246-1249
4. Garrett E.R., and Hunt C.A. Physiochemical properties, solubility, and protein binding of delta9-tetrahydrocannabinol. Journal of Pharmaceutical Sciences 63 (1974) 1056-1064
5. Giroud C., Augsburger M., Rivier L., and Mangin P. Hemp tea versus hemp milk: subjective effects and elimination studies of THC and its main metabolite. Proceedings of the 35th TIAFT meeting. Padova, Italy (1997) 112-121
6. Grotenhermen F., and Russo E. Cannabis and Cannabinoids (2002), Haworth Press, New York pp. 67-72
7. Hazekamp A. An evaluation of medicinal grade cannabis in The Netherlands. Cannabinoids 1 (2006) 1-9
8. Hazekamp A., and Verpoorte R. Structure elucidation of the tetrahydrocannabinol complex with randomly methylated beta-cyclodextrin. European Journal of Pharmaceutical Sciences 29 (2006) 340-347
9. Hazekamp A., Simons R., Peltenburg-Looman A., Sengers M., van Zweden R., and Verpoorte R. Preparative isolation of cannabinoids from Cannabis sativa by centrifugal partition chromatography. Journal of Liquid Chromatography and Related Technology 27 (2004) 2421-2439
10. Hazekamp A., Choi Y.H., and Verpoorte R. Quantitative analysis of cannabinoids from Cannabis sativa using 1H-NMR. Chemical & Pharmaceutical Bulletin 52 (2004) 718-721
11. ICH, 2006. The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Official website: www.ich.org. Website visited 15 July 2006.
12. Janse A.F.C., Breekveldt-Postma N.S., Erkens J.A., and Herings R.M.C. Pharmo rapport: medicinal gebruik van cannabis (2004), Pharmo Institute for Drug Outcome Research, Utrecht, The Netherlands
13. Lachenmeier D.W., Kroener L., and Musshoff F. Determination of cannabinoids in hemp food products by use of headspace solid-phase microextraction and gas chromatography-mass spectrometry. Analytical and Bioanalytical Chemistry 378 (2004) 183-189
14. Mannila J., Jarvinen T., Jarvinen K., Tarvainen M., and Jarho P. Effects of RM-beta-CD on sublingual bioavailability of delta(9)-tetrahydrocannabinol in rabbits. European Journal of Pharmaceutical Sciences 26 (2005) 71-77
15. OMC, Office of Medicinal Cannabis, The Netherlands, 2006. Official website: www.cannabisbureau.nl. Website visited 20 August 2006.
16. Rubin V., and Comitas L. Ganja in Jamaica, A Medical Anthropological Study of Chronic Marihuana Use (1975), Mouton, The Hague, The Netherlands
17. Shoyama Y., Yagi M., Nishioka I., and Yamauchi T. Biosynthesis of cannabinoid acids. Phytochemistry 14 (1975) 2189-2192
18. Steinagle G.C., and Upfal M. Concentration of marijuana metabolites in the urine after ingestion of hemp seed tea. Journal of Occupational & Environmental Medicine 41 (1999) 510-513
19. Struempler R.E., Nelson G., and Urry F.M. A positive cannabinoids workplace drug test following the ingestion of commercially available hemp seed oil. Journal of Analytical Toxicology 21 (1997) 283-285
20. Turner C.E., Elsohly M.A., and Boeren E.G. Constituents of Cannabis sativa L. XVII. A review of the natural constituents. Journal of Natural Products 43 (1980) 169-234
21. Veress T., Szanto J.I., and Leisztner L. Determination of cannabinoid acids by high-performance liquid chromatography of their neutral derivatives formed by thermal decarboxylation in an open reactor. Journal of Chromatography 520 (1990) 339-347
22. Verhoeckx K.C., Korthout H.A., van Meeteren-Kreikamp A.P., Ehlert K.A., Wang M., van der Greef J., Rodenburg R.J., and Witkamp R.F. Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways. International Immunopharmacology 6 4 (2006) 656-665
23. Zoller O., Rhyn P., and Zimmerli B. High-performance liquid chromatographic determination of delta9-tetrahydrocannabinol and the corresponding acid in hemp containing foods with special regard to the fluorescent properties of delta9-tetrahydrocannabinol. Journal of Chromatography A 872 (2000) 101-110